IL144952A0 - Nucleic acids encoding cd40/cd40l chimeric polypeptides, methods for their production and uses thereof - Google Patents

Nucleic acids encoding cd40/cd40l chimeric polypeptides, methods for their production and uses thereof

Info

Publication number: IL144952A0
Authority: IL; Israel
Prior art keywords: production; methods; nucleic acids; acids encoding; chimeric polypeptides
Prior art date: 1999-04-16

Application number

IL14495200A

Original Assignee

Hoffmann La Roche

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-04-16

Filing date

2000-04-13

Publication date

2002-06-30

1999-04-16 Priority claimed from EP99107611A external-priority patent/EP1067194A1/en

2000-04-13 Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche

2002-06-30 Publication of IL144952A0 publication Critical patent/IL144952A0/en

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70578—NGF-receptor/TNF-receptor superfamily, e.g. CD27, CD30, CD40, CD95
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Immunology (AREA)
Gastroenterology & Hepatology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Animal Behavior & Ethology (AREA)
General Chemical & Material Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Cell Biology (AREA)
Chemical Kinetics & Catalysis (AREA)
Toxicology (AREA)
Zoology (AREA)
Pharmacology & Pharmacy (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Peptides Or Proteins (AREA)

IL14495200A 1999-04-16 2000-04-13 Nucleic acids encoding cd40/cd40l chimeric polypeptides, methods for their production and uses thereof IL144952A0 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
EP99107611A EP1067194A1 (en)	1999-04-16	1999-04-16	Vectors containing a gene coding for CD40 and/or CD40L under the control of a cytokine-inducible promoter which is a human acute phase amyloid A gene promoter. Methods for their production and uses thereof
EP99113967		1999-07-17
PCT/EP2000/003318 WO2000063395A1 (en)	1999-04-16	2000-04-13	Nucleic acids encoding cd40/cd40l chimeric polypeptides, methods for their production and uses thereof

Publications (1)

Publication Number	Publication Date
IL144952A0 true IL144952A0 (en)	2002-06-30

Family

ID=26152970

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IL14495200A IL144952A0 (en)	1999-04-16	2000-04-13	Nucleic acids encoding cd40/cd40l chimeric polypeptides, methods for their production and uses thereof

Country Status (8)

Country	Link
EP (1)	EP1173589A1 (en)
JP (1)	JP2003508016A (en)
AR (1)	AR023482A1 (en)
AU (1)	AU3966200A (en)
CA (1)	CA2369820A1 (en)
IL (1)	IL144952A0 (en)
NO (1)	NO20015003L (en)
WO (1)	WO2000063395A1 (en)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE60143535D1 (en)	2000-10-02	2011-01-05	Novartis Vaccines & Diagnostic	HUMAN ANTIBODIES AGAINST CD40
AU2002221780A1 (en) *	2000-10-31	2002-05-15	F.Hoffmann-La Roche Ag	Nucleic acids encoding cd40/cd40l chimeric polypeptides, methods for their production and uses thereof
PT1684869E (en)	2003-11-04	2011-09-16	Novartis Vaccines & Diagnostic	Methods of therapy for b cell-related cancers
AU2004287480B2 (en)	2003-11-04	2011-09-15	Novartis Vaccines And Diagnostics, Inc.	Use of antagonist anti-CD40 antibodies for treatment of chronic lymphocytic leukemia
ATE474599T1 (en)	2003-11-04	2010-08-15	Novartis Vaccines & Diagnostic	USE OF ANTAGONIST ANTI-CD40 MONOCLONAL ANTIBODIES FOR THE TREATMENT OF MULTIPLE MYELOMA
PT1694360E (en)	2003-11-04	2010-12-13	Novartis Vaccines & Diagnostic	Use of antagonist anti-cd40 antibodies for treatment of autoimmune and inflammatory diseases and organ transplant rejection
PT1680141E (en)	2003-11-04	2010-12-20	Novartis Vaccines & Diagnostic	Methods of therapy for solid tumors expressing the cd40 cell-surface antigen
CA2608750A1 (en)	2005-05-18	2006-11-23	Novartis Ag	Methods for diagnosis and treatment of diseases having an autoimmune and/or inflammatory component
UA94264C2 (en)	2006-04-21	2011-04-26	Новартис Аг	Stable liquid antagonist anti-cd40 antibody-containing pharmaceutical composition
EP2066339B1 (en)	2006-09-18	2014-08-13	The Board Of Trustees Of The University Of Arkansas	Compositions and methods of enhancing immune responses
NZ585776A (en)	2007-10-30	2012-07-27	Univ Arkansas	Compositions and methods of enhancing immune responses to flagellated bacterium
WO2009059298A2 (en)	2007-11-01	2009-05-07	Board Of Trustees Of The University Of Arkansas	Compositions and methods of enhancinc immune responses to eimeria
JP5568807B2 (en) *	2008-06-06	2014-08-13	静岡県	Identification of melanoma markers using proteomic analysis
CN102811734B (en)	2010-01-21	2016-02-10	阿肯色大学评议会	Strengthen vaccine carrier and the method for immunne response
ES2753142T3 (en)	2010-06-09	2020-04-07	Univ Arkansas	Vaccine and methods to reduce a Campylobacter infection
WO2012075111A1 (en)	2010-11-30	2012-06-07	Novartis Ag	Uses of anti-cd40 antibodies in combination therapy for b cell-related cancers
ES2968398T3 (en)	2013-02-14	2024-05-09	Univ Arkansas	Compositions and methods for enhancing immune responses to Eimeria or limiting Eimeria infection
EP3578190A1 (en)	2013-03-15	2019-12-11	The Board of Trustees of the University of Arkansas	Compositions and methods of enhancing immune responses to enteric pathogens
TWI843057B (en)	2016-05-03	2024-05-21	阿肯色州大學董事會	Yeast vaccine vector including immunostimulatory and antigenic polypeptides and methods of using the same
CA3044424C (en) *	2016-11-21	2023-05-23	Nant Holdings Ip, Llc	Fractal combination therapy
CA3098498A1 (en) *	2018-06-14	2019-12-19	Nantbio, Inc.	Tnf-type receptor-ligand fusion proteins and methods
WO2020073045A1 (en) *	2018-10-05	2020-04-09	Nantcell, Inc.	Cd40 and cd40l combo in an adenovirus vaccine vehicle

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5716805A (en) *	1991-10-25	1998-02-10	Immunex Corporation	Methods of preparing soluble, oligomeric proteins
DE69233402T3 (en) *	1991-10-25	2009-06-25	Immunex Corp., Seattle	NEW CYTOKINE
US7070771B1 (en) *	1996-12-09	2006-07-04	Regents Of The University Of California	Methods of expressing chimeric mouse and human CD40 ligand in human CD40+ cells

2000
- 2000-04-13 CA CA002369820A patent/CA2369820A1/en not_active Abandoned
- 2000-04-13 WO PCT/EP2000/003318 patent/WO2000063395A1/en not_active Application Discontinuation
- 2000-04-13 IL IL14495200A patent/IL144952A0/en unknown
- 2000-04-13 JP JP2000612474A patent/JP2003508016A/en active Pending
- 2000-04-13 EP EP00918873A patent/EP1173589A1/en not_active Withdrawn
- 2000-04-13 AU AU39662/00A patent/AU3966200A/en not_active Abandoned
- 2000-04-13 AR ARP000101716A patent/AR023482A1/en unknown
2001
- 2001-10-15 NO NO20015003A patent/NO20015003L/en not_active Application Discontinuation

Also Published As

Publication number	Publication date
AR023482A1 (en)	2002-09-04
AU3966200A (en)	2000-11-02
EP1173589A1 (en)	2002-01-23
CA2369820A1 (en)	2000-10-26
WO2000063395A1 (en)	2000-10-26
NO20015003D0 (en)	2001-10-15
NO20015003L (en)	2001-10-15
JP2003508016A (en)	2003-03-04

Similar Documents

Publication	Publication Date	Title
IL144952A0 (en)	2002-06-30	Nucleic acids encoding cd40/cd40l chimeric polypeptides, methods for their production and uses thereof
AU2002221780A1 (en)	2002-05-15	Nucleic acids encoding cd40/cd40l chimeric polypeptides, methods for their production and uses thereof
WO2002101078A8 (en)	2013-11-28	Cellulases, nucleic acids encoding them and methods for making and using them
WO2003083054A9 (en)	2010-01-14	Amylases, nucleic acids encoding them and methods for making and using them
IN2004DE03129A (en)	2005-04-01	Phytases, nucleic acids encoding them and methods for making and using them
EP1727898A4 (en)	2009-11-04	Amylases, nucleic acids encoding them and methods for making and using them
PT1214097E (en)	2009-10-19	Nucleic acids encoding polyepitope polypeptides
WO2004033668A8 (en)	2008-06-05	Proteases, nucleic acids encoding them and methods for making and using them
EP1229125A4 (en)	2005-06-01	Process for producing polypeptide
ZA200500171B (en)	2010-06-30	Xylanases, nucleic acids encoding them and methods for making and using them
CZ20023563A3 (en)	2003-03-12	Process for preparing 2-halobenzoic acids
AU2001244609A1 (en)	2001-10-15	Novel protein, dna thereof and process for producing the same
HK1079813A1 (en)	2006-04-13	Nucleic acids, polypeptides, and methods for modulating apoptosis
AU2001296333A1 (en)	2002-04-08	Paad domain-containing polypeptides, encoding nucleic acids, and methods of use
AU2002339862A1 (en)	2003-05-26	Abrogen polypeptides, nucleic acids encoding them and methods for using them to inhibit angiogenesis
AU2002365905A8 (en)	2003-09-04	Transaminases, nucleic acids encoding them and methods of making and using them
PL3023498T3 (en)	2019-05-31	Amylases, nucleic acids encoding them and methods for making and using them
IL161765A0 (en)	2005-11-20	P85-alpha nucleic acids, polypeptides and related methods
AU2002330145A1 (en)	2003-04-07	Amidases, nucleic acids encoding them and methods for making and using them
AU1453601A (en)	2001-05-14	Novel polypeptides and nucleic acids encoding same
HUP0103361A2 (en)	2001-12-28	Factor viii homologue nucleic acids, polypeptides, methods, uses
ZA200004082B (en)	2001-02-12	A process for the fermentative preparation of metabolic products and for the nucleotide sequences encoding for the sod gene.
AU1486801A (en)	2001-05-30	Novel growth factor polypeptides and nucleic acids encoding same
AU2002254427A1 (en)	2002-10-15	Nucleic acids encoding isav polypeptides
ZA200102538B (en)	2002-09-30	Process for preparing substituted pyridines.